The Pharmacogenetics of CYP2C9 and CYP2C19: Ethnic Variation and Clinical Significance

E-ISSN： 2212-3938|2|1|93-109

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.2, Iss.1, 2007-01, pp. : 93-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population

By Scott Stuart A Edelmann Lisa Kornreich Ruth Erazo Monica Desnick Robert J

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 721-730

Future Medicine

Access to resources Recommend Favorite

Polymorphisms of CYP2C19 and CYP2D6 in Israeli Ethnic Groups

By Huai-Rong Luo

American Journal of PharmacoGenomics, Vol. 4, Iss. 6, 2004-01 ,pp. : 395-401

Adis International

Access to resources Recommend Favorite

Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups

By Scott Stuart A Khasawneh Rame Peter Inga Kornreich Ruth Desnick Robert J

Pharmacogenomics, Vol. 11, Iss. 6, 2010-06 ,pp. : 781-791

Future Medicine

Access to resources Recommend Favorite

Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro

By Pan Yan Tiong Kai Abd-Rashid Badrul Ismail Zakiah Ismail Rusli Mak Joon Ong Chin

Journal of Natural Medicines, Vol. 68, Iss. 2, 2014-04 ,pp. : 402-406

Springer Publishing Company

Access to resources Recommend Favorite

Multiplex genotyping of CYP3A4, CYP3A5, CYP2C9 and CYP2C19 SNPs using MALDI-TOF mass spectrometry

By Falzoi Matteo Mossa Alessandra Congeddu Elena Saba Luisella Pani Luca

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 559-571

Future Medicine

Access to resources Recommend Favorite